Litcius/Paper detail

Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND Trial

Alexander D. Sherry, Bilal A. Siddiqui, Cara Haymaker, Bryan Fellman, Marina Nayeli Medina-Rosales, Tharakeswara Bathala, Shuqi Wang, Suyu Liu, Aaron Seo, Kieko Hara, Hsin‐Yi Lu, Patricia Troncoso, Stephen G. Chun, Chul S. Ha, Lauren L. Mayo, Henry Mok, Ryan J. Park, Brian F. Chapin, Ryan Phillips, Matthew P. Deek, Craig A. Kovitz, Ana M. Aparicio, Amado J. Zurita, Patrick G. Pilié, Lorenzo Cohen, Seungtaek Choi, Alexandre Reuben, Phuoc T. Tran, Paul G. Corn, Sumit K. Subudhi, Chad Tang

2025European Urology24 citationsDOIOpen Access PDF

Topics & Concepts

MedicineProstate cancerAndrogen deprivation therapyRandomized controlled trialOncologyInternal medicineMetastasisUrologyCancerProstate Cancer Treatment and ResearchCancer Immunotherapy and BiomarkersProstate Cancer Diagnosis and Treatment
Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND Trial | Litcius